Company / R&D Expense
Health Catalyst, Inc. R&D Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$72.6M
FY2025
5-year range
$46.3M / $75.7M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $63M to $73M over the past 2 years.
Based on SEC 10-K filings.
$73M in FY2025 with a 5-year CAGR of +13.5%.
Improved from $63M to $73M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, r&d expense decreased 4.0% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $72.6M | -4.0% |
| FY2024 | $75.7M | +20.6% |
| FY2023 | $62.7M | +17.2% |
| FY2022 | $53.5M | +15.7% |
| FY2021 | $46.3M | +19.8% |
| FY2020 | $38.6M | +35.6% |
| FY2019 | $28.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026